清胃健脾法治疗幽门螺杆菌阳性慢性萎缩性胃炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R573.3+2

基金项目:

龙岩市科学技术局项目(2018LY5021)


Clinical Study on Stomach- Clearing and Spleen- Fortifying Method for Helicobacter Pylori-Positive Chronic Atrophic Gastritis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察清胃健脾法治疗幽门螺杆菌阳性慢性萎缩性胃炎的临床效果。方法:选取本院收治的 60 例胃热脾虚型患者作为研究对象,随机分为对照组和治疗组各 30 例。对照组采用四联疗法根除幽门螺杆菌,治疗组应用清胃健脾法方药进行治疗。2 组均用药 2 周。治疗前后应用生命质量测量与评价(QOL)量表评价患者的生活质量。疗程结束且停药 2 周后应用 13C-尿素呼气试验检测幽门螺杆菌,复查胃镜以评定临床疗效。结果:治疗后,治疗组临床疗效总有效率 96.67%,高于对照组的76.67%,差异有统计学意义(P<0.05)。2 组生活质量评分均较治疗前升高,差异均有统计学意义(P<0.01)。治疗组生活质量评分高于对照组,差异有统计学意义(P<0.01)。停药 2 周后,治疗组幽门螺杆菌阳性检出率为 6.67%,对照组为 26.67%,2 组比较,差异有统计学意义(P<0.05)。结论:应用清胃健脾法方药治疗胃热脾虚型慢性萎缩性胃炎患者具有较确切的治疗效果,可有效清除幽门螺杆菌,改善临床症状,提升患者的生活质量。

    Abstract:

    Abstract:Objective:To observe the clinical effect of stomach- clearing and spleen- fortifying method for helicobacter pylori-positive chronic atrophic gastritis. Methods:A total of 60 cases of patients of stomach heat and spleen deficiency type were selected as the study objects,and were randomly divided into the control group and the treatment group,30 cases in each group. The control group was given quadruple therapy to eradicate helicobacter pylori,and the treatment group was treated with stomach-clearing and spleen-fortifying method. Both groups were given drugs for two weeks. Before and after treatment,the quality of life of patients was evaluated by Quality of Life(QOL) scale. Two weeks after drug withdrawal, helicobacter pylori was detected by 13C- urea breath test, and clinical effect was assessed by re- examination of gastroscopy. Results:After treatment,the total effective rate of clinical effect was 96.67% in the treatment group,higher than that of 76.67% in the control group,the difference being significant(P<0.05). The scores of quality of life in the two groups were increased when compared with those before treatment,the difference being significant(P<0.01). The score of quality of life in the treatment group was higher than that in the control group,the difference being significant(P<0.01). Two weeks after drug withdrawal,the positive rate of helicobacter pylori was 6.67% in the treatment group and 26.67% in the control group, the difference being significant(P<0.05). Conclusion: The application of stomach- clearing and spleenfortifying method for chronic atrophic gastritis of stomach heat and spleen deficiency type has definite curative effect,and can effectively eradicate helicobacter pylori and improve clinical symptoms and quality of life.

    参考文献
    相似文献
    引证文献
引用本文

熊晓芳,张广政,高霖,李小兰.清胃健脾法治疗幽门螺杆菌阳性慢性萎缩性胃炎临床研究[J].新中医,2020,52(22):70-72

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-11-27
  • 出版日期:
文章二维码